Loading…
Rani Therapeutics Holdings, Inc. is projected to rise to $0.8195 by 2027, a +6% move from its current price of $0.7741. RANI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.7335 | $0.7745 | $0.8178 | +0.05% |
| Aug 6 | $0.7175 | $0.7749 | $0.8368 | +0.10% |
| Aug 7 | $0.7056 | $0.7753 | $0.8519 | +0.15% |
| Aug 8 | $0.6958 | $0.7757 | $0.8648 | +0.21% |
| Aug 9 | $0.6873 | $0.7761 | $0.8764 | +0.26% |
| Aug 10 | $0.6797 | $0.7765 | $0.8871 | +0.31% |
| Aug 11 | $0.6728 | $0.7769 | $0.8971 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6728 | $0.7769 | $0.8971 | +0.36% |
| Week 2 | $0.6362 | $0.7797 | $0.9556 | +0.72% |
| Week 3 | $0.6099 | $0.7825 | $1.00 | +1.09% |
| Week 4 | $0.589 | $0.7854 | $1.05 | +1.45% |
| Week 5 | $0.5714 | $0.7882 | $1.09 | +1.82% |
| Week 6 | $0.5561 | $0.791 | $1.13 | +2.19% |
| Week 7 | $0.5426 | $0.7939 | $1.16 | +2.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.
Its product pipeline includes RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat rheumatoid arthritis; RT-116 which is in discovery stage for the treatment of obesity; RT-117 for rare diseases; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions.
Rani Therapeutics was founded in 2012 and is headquartered in San Jose, California.
Rani Therapeutics Holdings, Inc. operates in the healthcare sector. The stock trades under the symbol RANI and has a current price of $0.8101 with a market capitalization of $111.38M, and it is ranked 3976 by market capitalization.
The near-term price outlook shows a neutral stance, with a 2026 average price of $0.8101 and a 2026 min of $0.633 and max of $1.10. The forecast indicates a neutral sentiment for 2026, with an implied return of 0% in that year.
Over the longer horizon, forecasts depict a path of fluctuation with notable upside later in the period. The 2030 forecast shows an average price of $0.7095 (min $0.4395; max $1.23) with a return of -12.4%, while 2040 projects an average of $1.49 (min $0.6705; max $3.27) with a return of 83.9%, and 2050 projects an average of $1.96 (min $0.8818; max $4.51) with a return of 141.9%.
A major floor 34.9% below — a decisive break under it would weaken the trend.
The nearest floor, 18.2% below — buyers have tended to step in here.
The nearest ceiling, 15.9% above — a clean break opens room to run.
A major ceiling 47.3% above — clearing it would confirm fresh momentum.
Key RANI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RANI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8134 | Sell | $0.8071 | Sell |
| MA 10 | $0.8082 | Sell | $0.7971 | Sell |
| MA 20 | $0.7494 | Buy | $0.7803 | Sell |
| MA 50 | $0.8056 | Sell | $0.8125 | Sell |
| MA 100 | $0.8964 | Sell | $0.9031 | Sell |
| MA 200 | $1.21 | Sell | $1.03 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.15 | Neutral |
| Stoch RSI (14) | 49.87 | Neutral |
| CCI (20) | 21.77 | Neutral |
| Williams %R (14) | -49.60 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 14.33 | Buy |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 50.40 | Neutral |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 35.71 | Neutral |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 0.81 | Sell |
| ADX (14) | 19.04 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is neutral. The RSI14 sits at 50, and the price is near the SMA50 of $0.8213 while well below the SMA200 of $1.20.
Key levels to watch are a support at $0.633 and a resistance at $0.897. The 30-day price range spans from $0.5473 to $1.20, highlighting a window of movement over the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.633 | $0.7741 | $1.04 | 0% | Neutral | |
| $0.597 | $0.8195 | $1.22 | +6% | Neutral | |
| $0.4743 | $0.6923 | $1.10 | -11% | Neutral | |
| $0.4771 | $0.7339 | $1.22 | -5% | Neutral | |
| $0.4341 | $0.7003 | $1.21 | -10% | Neutral | |
| $0.3582 | $0.604 | $1.08 | -22% | Bearish | |
| $0.5332 | $0.9378 | $1.73 | +21% | Bullish | |
| $0.589 | $1.08 | $2.05 | +39% | Bullish | |
| $0.5126 | $0.9769 | $1.90 | +26% | Bullish | |
| $0.5185 | $1.03 | $2.05 | +33% | Bullish | |
| $0.6586 | $1.46 | $3.21 | +89% | Bullish | |
| $0.8749 | $1.94 | $4.47 | +151% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.633 | $0.7741 | $0.9854 | +0.00% |
| September 2026 | $0.6889 | $0.8377 | $1.06 | +8.22% |
| October 2026 | $0.658 | $0.8113 | $1.05 | -3.15% |
| November 2026 | $0.6162 | $0.7684 | $1.01 | -5.29% |
| December 2026 | $0.618 | $0.7788 | $1.04 | +1.35% |
Click any year to see its month-by-month RANI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, RANI is projected to trade between $0.633 and $1.04, averaging $0.7741 — a potential gain of 0% from today's $0.7741. A consolidation phase looks the most probable path here.
Rani Therapeutics Holdings, Inc.'s 2027 outlook centres on $0.8195, within a $0.597 to $1.22 range. That is up +6% on the projected 2026 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2028, RANI could reach as high as $1.10, with a base case around $0.6923 and support toward $0.4743 — roughly -11% from $0.7741. A consolidation phase looks the most probable path here.
Expect RANI to range from $0.4771 to $1.22 through 2029. The $0.7339 average target implies a -5% move from current prices. That is up +6% on the projected 2028 average. Price action looks broadly range-bound.
The RANI price prediction for 2030 points to an average of $0.7003 (low $0.4341, high $1.21) — a potential decline of -10% on today's $0.7741. A consolidation phase looks the most probable path here.
In 2031, RANI is projected to trade between $0.3582 and $1.08, averaging $0.604 — a potential decline of -22% from today's $0.7741. That is -14% versus the projected 2030 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Rani Therapeutics Holdings, Inc.'s 2032 outlook centres on $0.9378, within a $0.5332 to $1.73 range. That is up +55% on the projected 2031 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, RANI could reach as high as $2.05, with a base case around $1.08 and support toward $0.589 — roughly +39% from $0.7741. Momentum favours further upside here.
Expect RANI to range from $0.5126 to $1.90 through 2034. The $0.9769 average target implies a +26% move from current prices. That is -9% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The RANI price prediction for 2035 points to an average of $1.03 (low $0.5185, high $2.05) — a potential gain of +33% on today's $0.7741. Momentum favours further upside here.
In 2040, RANI is projected to trade between $0.6586 and $3.21, averaging $1.46 — a potential gain of +89% from today's $0.7741. That is up +42% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Rani Therapeutics Holdings, Inc.'s 2050 outlook centres on $1.94, within a $0.8749 to $4.47 range. That is up +33% on the projected 2040 average. That marks a +151% change versus current levels. Momentum favours further upside here.
Investing $1,000 in RANI today (≈ 1,291.822762 RANI) could be worth
$2,511.51
+$1,511.51 (+151%) by 2050 · US Dollar
Based on the average projected RANI price of $1.94 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RANIwould be worth at today's price.
$1,000 invested in RANI on Jul 31, 2025 (≈ 1,865.671595 RANI) would be worth
$1,444.22
+$444.22 (+44.4%) today · 1.44× · US Dollar
Based on a RANI entry price of $0.536 vs. today's $0.7741.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.851 | $909.64 | -9.0% |
| 1 month ago | $0.768 | $1,007.94 | +0.8% |
| 3 months ago | $0.94 | $823.51 | -17.6% |
| 6 months ago | $1.2 | $645.08 | -35.5% |
| 1 year ago | $0.536 | $1,444.22 | +44.4% |
| All time (5.0y) ago | $11.81 | $65.55 | -93.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RANI forecast.
Our base-case forecast reaches $1.50 around 2050.
Implied market cap at $1.50: $168.58M
The multi-year forecast shows mixed to bullish dynamics after 2031. In 2031, the price is forecast to average $0.6067 with a bearish sentiment and a -25.1% ROI. The outlook turns bullish in 2032 (avg $0.966; ROI 19.2) and strengthens through 2033 (avg $1.10; ROI 35.8) and 2034 (avg $0.9949; ROI 22.8) before continuing higher in 2035 (avg $1.06; ROI 31.4).
The long-horizon view remains positive, with 2040 forecasting an average of $1.49 and an 83.9% ROI, and 2050 forecasting an average of $1.96 with a 141.9% ROI. Max price projections peak at $1.23 in 2030, $3.27 in 2040, and $4.51 in 2050, reflecting substantial upside potential alongside periods of decline.
Tap a question to reveal the answer.
2030 forecast: avg $0.7095; min $0.4395; max $1.23; ROI -12.4%; sentiment NEUTRAL.
Forecasts show mixed returns. Near term includes 2026 avg $0.8101 with 0% ROI, 2027 avg $0.854 (ROI 5.4%), and a dip through 2031 (e.g., 2031 avg $0.6067, ROI -25.1). Later years turn bullish, with 2040 avg $1.49 (ROI 83.9%) and 2050 avg $1.96 (ROI 141.9%). These are estimates, not guarantees.
Yes, according to the forecasts, it could reach a 2027 max of $1.27 and extend higher in later years, with max values of $2.09 in 2033, $3.27 in 2040, and $4.51 in 2050.
Current price is $0.8101 and market cap is $111.38M. The stock rank is 3976.
Sentiment is NEUTRAL with RSI14 at 50. The SMA50 is $0.8213 and the SMA200 is $1.20. Support is at $0.633 and resistance at $0.897; the 30-day range runs from $0.5473 to $1.20.
Rani Therapeutics Holdings, Inc. Community Discussion
0Share your Rani Therapeutics Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.